3
Announcements
Trials
Browse
Landscape
Phase
Phase 3
1
Status
Completed
1
Sponsor Class
INDUSTRY
1
Study Type
Interventional
1
Sponsor
Cancer Type
Gastrointestinal
1
Conditions
Myelodysplastic Syndromes
5
Neoplasms
4
Leukemia, Myeloid, Acute
4
Leukemia, Myelomonocytic, Chronic
3
Carcinoma, Squamous Cell
3
Primary Myelofibrosis
2
Precursor Cell Lymphoblastic Leukemia-Lymphoma
2
Leukemia, Myelogenous, Chronic, BCR-ABL Positive
2
Leukemia, Lymphocytic, Chronic, B-Cell
2
Leukemia
2
Head and Neck Neoplasms
2
Cytopenia
2
Anemia, Refractory, with Excess of Blasts
2
Waldenstrom Macroglobulinemia
1
Thrombocythemia, Essential
1
Squamous Cell Carcinoma of Head and Neck
1
Splenomegaly
1
Solid Tumor
1
Polycythemia Vera
1
Pancreatic Neoplasms
1
Ovarian Neoplasms
1
Neoplasm Metastasis
1
Myeloproliferative Disorders
1
Multiple Myeloma
1
Melanoma
1
Malignant Neoplasmas
1
Lymphoma, Mantle-Cell
1
Leukemia, Hairy Cell
1
Esophageal Squamous Cell Carcinoma
1
Epidermolysis Bullosa Dystrophica
1
Interventions
Gemcitabine
679
130-nm albumin-bound paclitaxel
198
Fluorouracil
186
Oxaliplatin
175
Albumin-Bound Paclitaxel
151
Capecitabine
137
Leucovorin
131
Irinotecan
113
Radiotherapy
95
Taxes
83
pembrolizumab
80
Cisplatin
72
Erlotinib Hydrochloride
69
Radiosurgery
67
Nivolumab
56
Bevacizumab
54
Drug Therapy
52
Cyclophosphamide
49
Magnetic Resonance Spectroscopy
46
folfirinox
42
Docetaxel
41
Cetuximab
40
Specimen Handling
37
irinotecan sucrosofate
36
S 1 (combination)
36
Biopsy
31
Radiation
29
Paclitaxel
29
Ipilimumab
27
durvalumab
26
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Interventional
×
Pancreatic Neoplasms
×
ON 01910
×
Clear all
NCT01360853
2016-08-04
ONTRAC
Traws Pharma, Inc.
Phase 3
Completed
160 enrolled